Pun zapis

dc:title	Perioperative Management of Antiplatelet and Anticoagulation Therapy in Vascular Surgery
dc:creator	tanaskovic, Slobodan
dc:creator	Petrovic, Jovan
dc:creator	Ševković, Milorad
dc:creator	Vučurević, Bojan
dc:creator	Bučić, Andriana
dc:creator	Bajčetić, Danica
dc:creator	Ilijevski, Nenad
dc:creator	Dabić, Petar
dc:subject	perioperative care
dc:subject	anticoagulation
dc:subject	antiplatelet therapy
dc:subject	vascular surgery
dc:subject	anticoagulant reversal
dc:subject	platelet aggregation
dc:subject	bleeding risk assessment
dc:subject	anticoagulants
dc:description	Treatment of patients taking anticoagulant therapy (ACT) and antiplatelet therapy (APT) is a daily challenge for doctors of all specialities, and a special problem is the adequate care of these patients in the immediate perioperative period during vascular surgical procedures. This paper presents the current findings and recommendations on the perioperative use of ACT and APT and considerations of therapeutic modalities in frequent clinical cases of vascular patients. An overview of the most commonly used anticoagulant and antiplatelet drugs in clinical practice is also presented. Vascular surgical patients represent a population of patients in whom platelet coagulation and aggregation mechanism are dysregulated in many cases. There is still no broad consensus and unequivocal evidence that can direct the physician towards the right modality of therapy. The final decision rests with the physician, who should, based on the individual assessment of each patient, determine the risk and thus determine the modality of anticoagulant and antiplatelet therapy.
dc:date	2023
dc:type	info:eu-repo/semantics/article
dc:type	info:eu-repo/semantics/publishedVersion
dc:identifier	https://stomatoloskifakultet.rs/nauka/publikacija/723
dc:identifier	DOI 10.59037/hjves.v5i2.47
dc:language	en
dc:rights	info:eu-repo/semantics/closedAccess
dc:rights	Sva prava zadržana